Matches in SemOpenAlex for { <https://semopenalex.org/work/W2131388327> ?p ?o ?g. }
- W2131388327 endingPage "107" @default.
- W2131388327 startingPage "100" @default.
- W2131388327 abstract "This study intended to assess the clinicopathological features of the histological subtypes of adenocarcinoma of the lung in a large registry population. The Japanese Joint Committee of Lung Cancer Registry performed a nationwide retrospective registry study on the prognosis and clinicopathological profiles of 11 663 patients who underwent resection for primary lung neoplasm in 2004. The registry data of 7921 (62.5%) patients with adenocarcinoma were analysed regarding the prognosis and clinicopathological features according to the histological subtype of adenocarcinoma. The histological subtypes were defined according to the 1999 World Health Organization classification (third edition), where bronchioloalveolar carcinoma (BAC) is defined as adenocarcinoma with a pure bronchioloalveolar growth pattern without invasion. The distribution of the histological subtype was acinar in 471 patients (7.5%), papillary in 2004 (32.2%), BAC in 1385 (22.3%), solid adenocarcinoma with mucin in 103 (1.7%) and adenocarcinoma with mixed subtypes (AMS) in 2257 (36.3%). The 5-year overall survival rates according to histological subtype were 63.4% for acinar, 72.9% for papillary, 90.3% for BAC, 54.4% for solid adenocarcinoma with mucin and 73.7% for AMS. While the survival rate in patients with BAC was significantly better than those for the other histological subtypes, acinar and solid adenocarcinoma with mucin had significantly worse prognoses than the other histological subtypes. The histological subtype was an independent predictor of survival in a multivariate analysis (P < 0.001). Regarding BAC, the pathological stage included not only Stage IA/IB (n = 1275; 92.1%), but also Stage II–IV (n = 110; 7.9%). One hundred twenty-five patients (9.0%) with BAC had recurrence, including both local and distant recurrence. The histological subtype in adenocarcinoma significantly correlated with the prognosis. In BACs with recurrence or pathological stage II–IV, these tumours might have been classified as invasive adenocarcinoma rather than as BAC. The need for the rigorous pathological evaluation of adenocarcinomas that are considered to be a preinvasive or minimally invasive tumour should be addressed in the new lung adenocarcinoma classification to be proposed by the International Association for the Study of Lung Cancer, the American Thoracic Society and the European Respiratory Society." @default.
- W2131388327 created "2016-06-24" @default.
- W2131388327 creator A5003016795 @default.
- W2131388327 creator A5006169496 @default.
- W2131388327 creator A5030798280 @default.
- W2131388327 creator A5030864419 @default.
- W2131388327 creator A5031327561 @default.
- W2131388327 creator A5044442302 @default.
- W2131388327 creator A5045237664 @default.
- W2131388327 creator A5062012032 @default.
- W2131388327 creator A5067647817 @default.
- W2131388327 creator A5074736475 @default.
- W2131388327 creator A5077482201 @default.
- W2131388327 date "2013-05-31" @default.
- W2131388327 modified "2023-09-25" @default.
- W2131388327 title "Differences in the prognosis of resected lung adenocarcinoma according to the histological subtype: a retrospective analysis of Japanese lung cancer registry data" @default.
- W2131388327 cites W1579851141 @default.
- W2131388327 cites W1963806079 @default.
- W2131388327 cites W1975178076 @default.
- W2131388327 cites W1980610830 @default.
- W2131388327 cites W1981445628 @default.
- W2131388327 cites W1984542868 @default.
- W2131388327 cites W2001372892 @default.
- W2131388327 cites W2002887395 @default.
- W2131388327 cites W2004896066 @default.
- W2131388327 cites W2006203617 @default.
- W2131388327 cites W2026676774 @default.
- W2131388327 cites W2032995263 @default.
- W2131388327 cites W2039454516 @default.
- W2131388327 cites W2040565926 @default.
- W2131388327 cites W2049674541 @default.
- W2131388327 cites W2076734146 @default.
- W2131388327 cites W2093092331 @default.
- W2131388327 cites W2101556010 @default.
- W2131388327 cites W2127445851 @default.
- W2131388327 cites W2163467768 @default.
- W2131388327 cites W4233769980 @default.
- W2131388327 cites W2136556532 @default.
- W2131388327 doi "https://doi.org/10.1093/ejcts/ezt284" @default.
- W2131388327 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/23729748" @default.
- W2131388327 hasPublicationYear "2013" @default.
- W2131388327 type Work @default.
- W2131388327 sameAs 2131388327 @default.
- W2131388327 citedByCount "23" @default.
- W2131388327 countsByYear W21313883272014 @default.
- W2131388327 countsByYear W21313883272015 @default.
- W2131388327 countsByYear W21313883272016 @default.
- W2131388327 countsByYear W21313883272017 @default.
- W2131388327 countsByYear W21313883272018 @default.
- W2131388327 countsByYear W21313883272019 @default.
- W2131388327 countsByYear W21313883272020 @default.
- W2131388327 countsByYear W21313883272021 @default.
- W2131388327 countsByYear W21313883272022 @default.
- W2131388327 crossrefType "journal-article" @default.
- W2131388327 hasAuthorship W2131388327A5003016795 @default.
- W2131388327 hasAuthorship W2131388327A5006169496 @default.
- W2131388327 hasAuthorship W2131388327A5030798280 @default.
- W2131388327 hasAuthorship W2131388327A5030864419 @default.
- W2131388327 hasAuthorship W2131388327A5031327561 @default.
- W2131388327 hasAuthorship W2131388327A5044442302 @default.
- W2131388327 hasAuthorship W2131388327A5045237664 @default.
- W2131388327 hasAuthorship W2131388327A5062012032 @default.
- W2131388327 hasAuthorship W2131388327A5067647817 @default.
- W2131388327 hasAuthorship W2131388327A5074736475 @default.
- W2131388327 hasAuthorship W2131388327A5077482201 @default.
- W2131388327 hasBestOaLocation W21313883271 @default.
- W2131388327 hasConcept C121608353 @default.
- W2131388327 hasConcept C126322002 @default.
- W2131388327 hasConcept C142724271 @default.
- W2131388327 hasConcept C143998085 @default.
- W2131388327 hasConcept C146357865 @default.
- W2131388327 hasConcept C151730666 @default.
- W2131388327 hasConcept C167135981 @default.
- W2131388327 hasConcept C207886595 @default.
- W2131388327 hasConcept C2776256026 @default.
- W2131388327 hasConcept C2776283816 @default.
- W2131388327 hasConcept C2777546739 @default.
- W2131388327 hasConcept C2777714996 @default.
- W2131388327 hasConcept C2778527826 @default.
- W2131388327 hasConcept C2779563347 @default.
- W2131388327 hasConcept C2781182431 @default.
- W2131388327 hasConcept C71924100 @default.
- W2131388327 hasConcept C86803240 @default.
- W2131388327 hasConceptScore W2131388327C121608353 @default.
- W2131388327 hasConceptScore W2131388327C126322002 @default.
- W2131388327 hasConceptScore W2131388327C142724271 @default.
- W2131388327 hasConceptScore W2131388327C143998085 @default.
- W2131388327 hasConceptScore W2131388327C146357865 @default.
- W2131388327 hasConceptScore W2131388327C151730666 @default.
- W2131388327 hasConceptScore W2131388327C167135981 @default.
- W2131388327 hasConceptScore W2131388327C207886595 @default.
- W2131388327 hasConceptScore W2131388327C2776256026 @default.
- W2131388327 hasConceptScore W2131388327C2776283816 @default.
- W2131388327 hasConceptScore W2131388327C2777546739 @default.
- W2131388327 hasConceptScore W2131388327C2777714996 @default.
- W2131388327 hasConceptScore W2131388327C2778527826 @default.
- W2131388327 hasConceptScore W2131388327C2779563347 @default.
- W2131388327 hasConceptScore W2131388327C2781182431 @default.